VetVine - Lymphoma: The state of this disease in dogs and how epigenetics may open future doors

Continuing Education » Oncology » Lymphoma: The state of this disease in dogs and how epigenetics may open future doors

Lymphoma: The state of this disease in dogs and how epigenetics may open future doors

CE Event Information

Description:
Join us in this session and learn about the current state of diagnosis and treatment of canine lymphoma. Discussion includes: the prognostic significance of lymphoma type, how the type influences treatment decisions, current therapies that are employed, and what the future might hold for new treatments for the disease. Finally, we discuss what epigenetics are, the relevance to their study in cancers like lymphoma, and how they may influence future disease understanding.

At the conclusion of the lecture, the attendee will understand:

- Broad categories of canine lymphoma
- Current therapies for these categories
- Emerging new therapies
- The significance of DNA methylation in the development of cancer
- How DNA methylation might impact risk assessment, diagnosis, and treatment

(Running time: 42 mins, followed by 13 mins of Q and A with Dr. Jeffrey Bryan)

Fee: Free for Premium Membership subscribers
or pay-per-view ($28)
Sponsor: AKC Canine Health Foundation
Presenter(s): Jeffrey N. Bryan, DVM, MS, PhD, DACVIM (Oncology)
Fee (Basic Membership): $28

Featured Publications

The following journal articles or textbook chapters have been selected as Supplements to this event. You can elect to purchase them as part of a discounted seminar package fee.

Prepaid CE Subscribers will be assessed a supplement fee for articles purchased.

	or Cancel
Remember my choice

Lymphoma: The state of this disease in dogs and how epigenetics may open future doors

CE Event Information

Featured Publications

Article Outline